Evidence map›Paper›PMID 28958974›Full record

ArticleBalkan medical journal2018

Myeloid Neoplasia and Lymphoblastic Lymphoma with Eosinophilia After Radioactive Iodine: A Case Report.

Mahmut Büyükşimşek, Semra Paydaş, Ali Oğul, Emine Bağır, Melek Ergin

Open access · diamondAbstract readCase Reports
In one paragraph

Article in Balkan medical journal, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
0.7field-weighted citation impact, top 28% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 4 citations in OpenAlex.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 1 institution in 1 country.

Mahmut BüyükşimşekDepartment of Oncology, Çukurova University School of Medicine, Adana, Turkey.
Semra PaydaşDepartment of Oncology, Çukurova University School of Medicine, Adana, Turkey.
Ali OğulDepartment of Oncology, Çukurova University School of Medicine, Adana, Turkey.
Emine BağırDepartment of Pathology, Çukurova University School of Medicine, Adana, Turkey.
Melek ErginDepartment of Pathology, Çukurova University School of Medicine, Adana, Turkey.
Cukurova University · TR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundThyroid cancer is the most common endocrine cancer, with an increasing incidence around the world in the last three decades. The increased risk of secondary cancer is associated with a genetic predisposition or radioactive iodine used in the treatment. CASE REPORT: A 65-year old male patient was operated on for thyroid papillary cancer. He received radioactive iodine on two occasions postoperatively. After six years, he presented with malaise and fatigue with leukocytosis and eosinophlilia. The physical examination revealed inguinal lymphadenopathies and splenomegaly, after examining the bone marrow and lymph node biopsies, he was diagnosed with eosinophilic myeloproliferative neoplasia and T-cell lymphoblastic leukaemia/lymphoma.

conclusionLeukaemia and other haematological malignencies may develop after radioactive iodine treatment. Patients with radioactive iodine ablation history should be monitored for a long time.

Indexed as

AgedEosinophiliaHumansIodine RadioisotopesMalePositron Emission Tomography Computed TomographyPrecursor Cell Lymphoblastic Leukemia-LymphomaThyroid Cancer, PapillaryThyroid NeoplasmsTissue DistributionIodine-131Iodine RadioisotopesIodinelymphomamyeloid neoplasm radioactive treatment.

Identifiers

PMID28958974
PMCPMC5863261
OpenAlexW2757172626

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.